CLINICAL_TRIALS
trial_result
· 2025-06-25
Clinical Trial Update: Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis [Phase 3]
Summary
Phase 3 trial evaluating ruxolitinib cream in adolescents with atopic dermatitis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Atopic Dermatitis (AD) | Phase 3 | Status: COMPLETED | Results posted: 2025-06-25